Skip to content
Parakho

Zydus Lifesciences Ltd

NSE ZYDUSLIFEBSE 532321

Q1 FY27, unaudited

Revenue
₹8,017.00 Cr
Profit after tax
₹990.20 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations8,017.00+21.96%27,148.40
Other income106.10−31.50%509.50
Total income8,123.10+20.72%27,657.90
Employee benefit expense1,368.20+36.11%4,417.90
Finance costs156.00+84.18%438.90
Depreciation & amortisation554.70+132.97%1,408.00
Total expenses6,798.30+41.40%20,520.20
Profit before tax1,306.60−31.97%6,621.10
Tax expense354.20−18.39%1,594.70
Profit after tax990.20−34.90%5,123.50
Total comprehensive income957.70−37.24%4,348.70
Earnings per share
Earnings per share, basic₹9.35₹50.09
Earnings per share, diluted₹9.35₹50.09

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — unaudited, from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Zydus Lifesciences reported consolidated revenue of ₹271.5 billion for FY26, up 17% year-on-year, with EBITDA margin at 31.2% and net profit adjusted for exceptional items at ₹54.6 billion, up 15%. Q4 FY26 revenue was ₹75.9 billion, up 16% year-on-year, with EBITDA margin of 33.7% and adjusted net profit of ₹15.9 billion. Management discussed growth across US formulations, India branded formulations, international markets, consumer wellness and medical devices, along with the proposed acquisition of Assertio Holdings and other pipeline updates.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 104 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 25 Aug 2026.